Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
about
Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib TherapySuboptimal responses in chronic myeloid leukemia: implications and management strategiesChronic myeloid leukemia treatment guidelines: Brazilian Association of Hematology, Hemotherapy and Cell Therapy. Brazilian Medical Association Guidelines Project - 2012.Management of imatinib-resistant patients with chronic myeloid leukemia.Therapeutic drug monitoring and tyrosine kinase inhibitors.Nilotinib: in the first-line treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia in chronic phase.The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia
P2860
Q33397085-C601CC95-4010-4FA1-A4D6-AC123895FBBCQ33399101-5CF966C9-FBED-4900-8A55-00B5B8DC80DCQ35667438-0B84E2E9-8414-49FA-B766-126303F4A27EQ36144079-5B7F4533-F588-4CBD-A084-7B2548BFB774Q36364850-E41368FE-CEF9-49BB-B951-B284BFC0FADCQ36776423-F22ADC71-58A3-463F-AC9D-A3A71DB00D38Q41846251-B3AA4FFD-86E7-4500-A2DE-C80F5F26096FQ42613843-1FB1F6E4-B972-4EAC-B349-5CED103027DDQ56973578-DC5CA939-8D18-421A-8DAE-CDD2DFCF1A63
P2860
Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@en
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@nl
type
label
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@en
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@nl
prefLabel
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@en
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@nl
P2093
P356
P1433
P1476
Chronic myelogenous leukemia: ...... osis, treatment and follow-up.
@en
P2093
ESMO Guidelines Working Group
M Baccarani
M Dreyling
P304
P356
10.1093/ANNONC/MDP143
P478
20 Suppl 4
P577
2009-05-01T00:00:00Z